Jennifer V.

Jennifer V. has worked in the field of clinical pharmacology and pharmacometrics for over 20 years. Jennifer began their career in 1998 as a Scientist in Inhalation Pharmacokinetics at PathoGenesis. Jennifer then moved to ZymoGenetics in 2000, where they served as Director of Pharmacokinetics and Pharmacodynamics. In 2007, Jennifer joined Genentech as Associate Director/Senior Scientist in Clinical Pharmacology. In 2014, they were appointed Director of Clinical Pharmacology and Modeling and Simulation at Amgen. In 2016, Jennifer moved to Certara as Vice President of Certara Strategic Consulting Clinical Pharmacology, Modeling and Simulation. In 2018, they joined UNITY Biotechnology as Vice President of Translational and Quantitative Sciences and Executive Director of Quantitative Sciences. In 2020, they were appointed Senior Program Officer of Quantitative Sciences at the Bill & Melinda Gates Foundation. Most recently, Jennifer was appointed Executive Director of Clinical Pharmacology and Pharmacometrics at Asher Biotherapeutics in 2022.

Jennifer V. received their PhD in Pharmaceutics and Pharmacokinetics from Virginia Commonwealth University in 1996. Prior to that, they earned their BS in Chemistry from James Madison University in 1990.